Federal Register / Vol. 62, No. 215 / Thursday, November 6, 1997 / Notices 60097

report and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individual

associated with the programs, disclosure of

which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog Of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research, 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research, 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93,399, Cancer Control)

Dated: October 30, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–29365 Filed 11–5–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Acrylonitrile Study Advisory Panel,

National Cancer Institute, National

Institutes of Health, on Thursday,

December 11, 1997. The meeting will be

held in Conference Room G, Executive

Plaza North, 6130 Executive Boulevard,

Rockville, Maryland 20892.

This meeting will be open to the

public from 10:00 a.m. to adjournment

to discuss results of the epidemiologic

study of workers exposed to

acrylonitrile, describe plans for worker

notification of the results, and present

plans for future mortality follow-up of

the cohort. Attendance by the public

will be limited to space available.

Mrs. Linda Quick-Cameron,

Committee Management Officer,

National Cancer Institute, Executive

Plaza North, Room 601, National

Institutes of Health, Bethesda, Maryland

20892 (301/496–5708) will provide

summaries of the meeting and rosters of

committee members, upon request.

Dr. Aaron Blair, Executive Secretary,

Division of Cancer Etiology, National

Cancer Institute, National Institutes of

Health, Executive Plaza North, Room

415, 6130 Executive Boulevard,

Rockville, Maryland 20892–7364 (301/

496–9093) will furnish substantive

program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other special

accommodations, should contact Dr.

Aaron Blair, (301) 496–9093, in advance

of the meeting.

Dated: October 30, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–29366 Filed 11–5–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meetings in conjunction with the

National Institute of Dental Research

and the National Institute of Arthritis

and Musculoskeletal and Skin Diseases:

Name of SEP: Tissue Engineering,

Biomimetics, and Medical Implant Science

Session I, NHLBI/NIDR/NIAMS.

Date: January 28–29, 1998.

Time: 7:00 p.m. EST.

Place: Bestheda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, Maryland 20814.

Contact Person: Diane M. Reid, M.D., Two

Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Tissue Engineering,

Biomimetics, and Medical Implant Science

Session II, NHLBI/NIDR/NIAMS.

Date: January 29–30, 1998.

Time: 7:00 p.m. EST.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, Maryland 20814.

Contact Person: Diane M. Reid, M.D., Two

Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: October 30, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–29361 Filed 11–5–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meeting:

Name of SEP: Sarcoidosis Genetic Linkage

Consortium.

Dates: December 12, 1997.

Time: 8:30 a.m. EST.

Place: Sheraton Crystal City Hotel, 1800

Jefferson Davis Highway, Arlington, Virginia

22202.

Contact Person: C. James Scheirer, Ph.D.,

Two Rockledge Center, Room 7220, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0266.

Purpose/Agenda: To review and evaluate

grant applications.

This meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: October 30, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–29362 Filed 11–5–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Diabetes and

Digestive and Kidney Diseases Special

Emphasis Panel meeting:

Name of SEP: ZDK1–GRB–6–J–1.

Date: December 3, 1997.

Time: 11:30 AM.

Place: Room 6as–25E, Natcher Building,

NIH (Telephone Conference Call).